- Report
- May 2022
- 165 Pages
Global
From €2476EUR$2,500USD£2,087GBP
- Report
- May 2022
- 148 Pages
Global
From €2476EUR$2,500USD£2,087GBP
- Report
- May 2022
- 40 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 35 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 54 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 81 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 37 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 106 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 171 Pages
Global
From €2476EUR$2,500USD£2,087GBP
- Report
- May 2022
- 65 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 36 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 41 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 45 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 70 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 42 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 39 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 132 Pages
Global
From €2476EUR$2,500USD£2,087GBP
- Report
- May 2022
- 36 Pages
Global
From €1981EUR$2,000USD£1,670GBP
- Report
- May 2022
- 236 Pages
Global
From €2476EUR$2,500USD£2,087GBP
- Report
- May 2022
- 170 Pages
Global
From €2476EUR$2,500USD£2,087GBP
The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more